KEYNOTE ‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive , advanced NSCLC
Autor: | Shengxiang Ren, Jifeng Feng, Shenglin Ma, HuaJun Chen, Zhiyong Ma, Cheng Huang, Li Zhang, Jianxing He, Changli Wang, Jianying Zhou, Pongwut Danchaivijtr, Chin‐Chou Wang, Ihor Vynnychenko, Kai Wang, Francisco Orlandi, Virote Sriuranpong, Ben Li, Jun Ge, Thao Dang, Caicun Zhou |
---|---|
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | International Journal of Cancer. |
ISSN: | 1097-0215 0020-7136 |
DOI: | 10.1002/ijc.34532 |
Databáze: | OpenAIRE |
Externí odkaz: |